Education
About Us
Working with TipRanks
Follow Us
Adaptimmune Therapeutics (ADAPY)
OTHER OTC:ADAPY
See the Price Targets and Ratings of:
ADAPY Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Barclays
$0.46
Sell
820.00%
Upside
Reiterated
08/14/25
Leerink Partners
$0.11→$0.09
Hold
80.00%
Upside
Reiterated
08/13/25
Guggenheim
―
Hold
―
Downgraded
07/29/25
H.C. Wainwright
―
Hold
―
Downgraded
07/29/25
Wells Fargo
$1.5→$1
Hold
1900.00%
Upside
Reiterated
05/14/25
Scotiabank
$1.4
Buy
2700.00%
Upside
Reiterated
05/14/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Barclays
$0.46
Sell
820.00%
Upside
Reiterated
08/14/25
Leerink Partners
$0.11→$0.09
Hold
80.00%
Upside
Reiterated
08/13/25
Guggenheim
―
Hold
―
Downgraded
07/29/25
H.C. Wainwright
―
Hold
―
Downgraded
07/29/25
Wells Fargo
$1.5→$1
Hold
1900.00%
Upside
Reiterated
05/14/25
Scotiabank
$1.4
Buy
2700.00%
Upside
Reiterated
05/14/25
Best Analysts Covering Adaptimmune Therapeutics
1 Month
xxx
Success Rate
8/12 ratings generated profit
Average Return
+5.47%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of +5.47% per trade.
3 Months
xxx
Success Rate
8/12 ratings generated profit
Average Return
+16.35%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +16.35% per trade.
1 Year
Success Rate
10/12 ratings generated profit
Average Return
+50.70%
reiterated a sell rating 4 months ago
Copying Peter Lawson's trades and holding each position for 1 Year would result in 83.33% of your transactions generating a profit, with an average return of +50.70% per trade.
2 Years
xxx
Success Rate
11/12 ratings generated profit
Average Return
+68.65%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 91.67% of your transactions generating a profit, with an average return of +68.65% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
ADAPY Analyst Recommendation Trends
Rating
Jul 25
Aug 25
Sep 25
Oct 25
Nov 25
Strong Buy
2
0
0
0
0
Buy
0
0
0
0
0
Hold
18
18
17
15
11
Sell
1
1
1
1
0
Strong Sell
0
4
6
8
9
total
21
23
24
24
20
Each month's total comprises the sum of three months' worth of ratings.
ADAPY Stock Forecast FAQ
What is ADAPY’s average 12-month price target, according to analysts?
Currently, no data Available
What is ADAPY’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for ADAPY, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ADAPY a Buy, Sell or Hold?
Currently, no data Available
What is Adaptimmune Therapeutics’s price target?
Currently, no data Available
What do analysts say about Adaptimmune Therapeutics?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of ADAPY?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.